Pentixapharm

Description: PentixaPharm develops theranostic radiopharmaceuticals targeting CXCR4 for fast-progressing diseases, focusing on CNS Lymphoma trials & other indications.

Country: Germany

Based in: Wuerzburg

Founded: 2019

Funding Stage: Series A/B

Tags: ['Biotechnology', 'Health Care', 'Life Science', 'Pharmaceutical']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.